Diabetes in Pregnancy: GDM Targets & Insulin for MRCP Part 1
- Crack Medicine
- 7 hours ago
- 4 min read
TL;DR
Gestational diabetes mellitus (GDM) is a frequently tested topic in MRCP Part 1, particularly around diagnostic criteria, glucose targets and insulin therapy in pregnancy. Candidates should know NICE diagnostic thresholds, safe insulin choices, common fetal complications and when to escalate treatment beyond lifestyle modification. Questions commonly test practical management decisions and medication safety in pregnancy.
Why This Topic Matters in MRCP Part 1
GDM affects a significant proportion of pregnancies worldwide and is increasingly common due to rising obesity and type 2 diabetes prevalence.
Poor glycaemic control during pregnancy increases the risk of:
Macrosomia
Shoulder dystocia
Polyhydramnios
Neonatal hypoglycaemia
Pre-eclampsia
Caesarean delivery
Future maternal type 2 diabetes
In MRCP Part 1, candidates are commonly tested on:
Diagnostic thresholds
Glycaemic targets
Safe insulin therapy
Drug contraindications
Maternal and fetal complications
Core Section 1: Diagnostic Criteria for GDM
In UK clinical practice, NICE guidance is commonly used.
NICE Diagnostic Thresholds
Test | Diagnostic Threshold |
Fasting plasma glucose | ≥5.6 mmol/L |
2-hour plasma glucose after OGTT | ≥7.8 mmol/L |
Women with risk factors are usually offered screening earlier in pregnancy.
High-Risk Groups
Previous gestational diabetes
BMI >30 kg/m²
Previous baby weighing >4.5 kg
First-degree relative with diabetes
South Asian, Black Caribbean or Middle Eastern ethnicity
High-Yield MRCP Point
Previous gestational diabetes is one of the strongest predictors of recurrence and is a common exam stem clue.
Core Section 2: Glycaemic Targets in Pregnancy
This is one of the most commonly examined areas.
Recommended Glucose Targets
Timing | Target |
Fasting glucose | <5.3 mmol/L |
1-hour post-meal | <7.8 mmol/L |
2-hour post-meal | <6.4 mmol/L |
Pregnancy requires tighter glycaemic control because maternal hyperglycaemia stimulates fetal insulin production, increasing the risk of macrosomia and neonatal complications.
Key Exam Insight
Persistent fasting hyperglycaemia despite dietary modification usually indicates the need for basal insulin.
Core Section 3: Insulin Therapy in Pregnancy
Lifestyle modification remains first-line treatment, but insulin is indicated if glucose targets are not achieved.
When to Start Insulin
Insulin should be considered when:
Lifestyle measures fail after 1–2 weeks
Fasting glucose remains elevated
Ultrasound shows fetal macrosomia
Hyperglycaemia is severe at diagnosis
Candidates practising with the Crack Medicine MRCP QBank should focus on identifying when escalation from diet to insulin is required.
Common Insulin Approaches
Clinical Pattern | Preferred Insulin Strategy |
Raised fasting glucose | Basal insulin |
Post-prandial hyperglycaemia | Rapid-acting insulin |
Mixed hyperglycaemia | Basal-bolus regimen |
Insulins Considered Safe in Pregnancy
Insulin lispro
Insulin aspart
NPH insulin
Insulin detemir
Frequently Tested Point
Older MRCP-style questions may favour NPH insulin, but newer guidelines increasingly accept long-acting analogues such as detemir.
Core Section 4: Oral Hypoglycaemic Agents
Metformin in Pregnancy
Metformin is widely used in gestational diabetes and is considered safe in UK practice.
Advantages include:
Oral administration
Less maternal weight gain
Reduced insulin requirements
However, some women still require insulin supplementation for adequate glycaemic control.
Drugs Contraindicated in Pregnancy
Drug/Class | Reason |
ACE inhibitors | Fetal renal toxicity |
Statins | Potential teratogenicity |
SGLT2 inhibitors | Insufficient pregnancy safety data |
Most oral hypoglycaemics outside metformin | Limited evidence/safety concerns |
High-Yield Trap
Do not confuse treatment strategies for pre-existing diabetes with those for gestational diabetes.
Core Section 5: Maternal and Fetal Complications
Maternal Complications
Pre-eclampsia
Caesarean delivery
Polyhydramnios
Future type 2 diabetes mellitus
Fetal and Neonatal Complications
Macrosomia
Shoulder dystocia
Neonatal hypoglycaemia
Respiratory distress syndrome
Neonatal jaundice
Important MRCP Distinction
Congenital malformations are more strongly associated with poorly controlled pre-existing diabetes than with late-onset gestational diabetes.
The 10 Highest-Yield MRCP Facts
Fasting plasma glucose ≥5.6 mmol/L diagnoses GDM.
Insulin is safe during pregnancy.
Metformin is commonly used in GDM.
Tight glycaemic control reduces macrosomia risk.
Persistent fasting hyperglycaemia suggests need for basal insulin.
Previous GDM significantly increases recurrence risk.
Neonatal hypoglycaemia is a classic complication.
Shoulder dystocia is associated with fetal macrosomia.
ACE inhibitors are contraindicated in pregnancy.
Women with GDM require post-partum diabetes screening.
Mini-Case for MRCP Part 1
A 30-year-old woman at 31 weeks’ gestation has gestational diabetes managed with dietary modification. Her fasting glucose readings remain between 5.8 and 6.2 mmol/L despite good adherence to dietary advice. Her post-prandial glucose values are largely within target.
What is the most appropriate next step?
A. Continue dietary management onlyB. Start basal insulinC. Add an ACE inhibitorD. Begin an SGLT2 inhibitorE. Stop glucose monitoring
Correct Answer: B. Start basal insulin
Explanation
Persistent fasting hyperglycaemia despite lifestyle measures indicates inadequate overnight glycaemic control. Basal insulin is the preferred escalation strategy.
ACE inhibitors and SGLT2 inhibitors are contraindicated during pregnancy.
Candidates should reinforce these management algorithms through timed SBA practice and MRCP mock tests.
The 5 Most Tested Subtopics
1. Diagnostic Thresholds
Know fasting and OGTT cut-offs accurately.
2. Glycaemic Targets
Remember fasting and post-prandial treatment targets separately.
3. Safe Medications
Insulin and metformin are commonly tested.
4. Fetal Complications
Macrosomia and neonatal hypoglycaemia appear frequently in questions.
5. Post-Partum Follow-Up
Women with GDM require future diabetes screening due to increased long-term risk.
Practical Study Checklist
Before the exam, ensure you can:
Differentiate GDM from pre-existing diabetes
Recall NICE diagnostic thresholds
Identify fasting versus post-prandial hyperglycaemia
Choose appropriate insulin strategies
Recognise contraindicated drugs
Recall fetal complications of maternal hyperglycaemia
Interpret glucose monitoring charts
Understand post-partum diabetes screening recommendations
For structured revision, combine topic reading with MRCP video lectures and regular SBA practice.
Common Pitfalls
Confusing diagnostic thresholds with treatment targets
Assuming congenital malformations are equally common in late GDM
Forgetting that metformin is commonly used in pregnancy
Missing the significance of fasting hyperglycaemia
Selecting contraindicated medications such as ACE inhibitors
FAQs
What glucose targets are used in gestational diabetes?
Typical targets are fasting glucose below 5.3 mmol/L, 1-hour post-meal below 7.8 mmol/L and 2-hour post-meal below 6.4 mmol/L. Tight glycaemic control reduces fetal complications.
Is metformin safe during pregnancy?
Yes. Metformin is commonly used in gestational diabetes in UK practice, although some patients still require insulin therapy.
What is the most common fetal complication of GDM?
Macrosomia is one of the most frequently tested complications and increases the risk of shoulder dystocia and operative delivery.
When should insulin be started in gestational diabetes?
Insulin is considered when lifestyle modification fails to achieve target glucose levels, particularly when fasting hyperglycaemia persists.
Does gestational diabetes increase future diabetes risk?
Yes. Women with previous GDM have a significantly increased risk of developing type 2 diabetes later in life and require ongoing follow-up.
Ready to start?
Preparing for endocrinology and obstetric medicine questions in MRCP Part 1 requires repeated exposure to clinical scenarios and management pathways. Explore the MRCP Part 1 overview, practise with the Crack Medicine QBank and strengthen weaker areas using MRCP lectures.
Sources
NICE Guideline NG3: Diabetes in Pregnancy
MRCP(UK) Examination Information
British National Formulary (BNF)
American Diabetes Association Standards of Care
Comments